Skip to main content
Eugene Bauer, MD, Dermatology, Stanford, CA

EugeneAndrewBauerMD

Dermatology Stanford, CA

Emeritus Faculty, Academic Council, Dermatology, Stanford University Medical Center

Dr. Bauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bauer's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1968 - 1974
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1967 - 1968
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1967

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2026
  • MO State Medical License
    MO State Medical License 1971 - 2017
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine/National Academy of Medicine, 1997
  • Elected Member ASCI, AAP, 1980, 1984

Publications & Presentations

PubMed

Press Mentions

  • Evommune Initiates Phase 2a Proof-of-Concept Clinical Trial to Evaluate EVO101 in Atopic Dermatitis
    Evommune Initiates Phase 2a Proof-of-Concept Clinical Trial to Evaluate EVO101 in Atopic DermatitisSeptember 28th, 2022
  • Ex-Dermira Founders Pick up $83M for Evommune to Advance Programs in-Licensed from Lilly's Dermira
    Ex-Dermira Founders Pick up $83M for Evommune to Advance Programs in-Licensed from Lilly's DermiraSeptember 9th, 2021
  • Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development of Food Allergy Therapeutics
    Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development of Food Allergy TherapeuticsFebruary 24th, 2020
  • Join now to see all

Professional Memberships